Genopathy
Gene-Disorder Association · Article
Gene
TTR
Transthyretin
Manually curatedApproved treatment annotated
Association Review

In brief

The association between TTR (Transthyretin) and Atrial Standstill 1 is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 13
Compounds 1
Trials 10of 40 via TTR compounds
Publications 23
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
TTR

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Atrial Standstill 1

The disorder

17 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

7 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

1 compound or drug

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

40 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

23 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

15 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access